Siamak Daneshmand
#148,151
Most Influential Person Now
Researcher
Siamak Daneshmand's AcademicInfluence.com Rankings
Siamak Daneshmandcomputer-science Degrees
Computer Science
#7592
World Rank
#7992
Historical Rank
Computational Linguistics
#1535
World Rank
#1552
Historical Rank
Machine Learning
#2845
World Rank
#2880
Historical Rank
Artificial Intelligence
#3138
World Rank
#3184
Historical Rank
Download Badge
Computer Science
Siamak Daneshmand's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Siamak Daneshmand Influential?
(Suggest an Edit or Addition)Siamak Daneshmand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (2017) (1446)
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. (2016) (915)
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. (2016) (426)
- Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. (2004) (313)
- Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. (2014) (272)
- Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. (2015) (251)
- Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes (2014) (246)
- Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. (2015) (227)
- A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. (2012) (223)
- Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. (2011) (214)
- Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. (2007) (209)
- Enhanced recovery protocol after radical cystectomy for bladder cancer. (2014) (204)
- ctDNA guiding adjuvant immunotherapy in urothelial carcinoma (2021) (179)
- Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles. (2012) (166)
- Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. (2021) (153)
- Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. (2005) (152)
- A critical analysis of perioperative mortality from radical cystectomy. (2006) (151)
- Benign retroperitoneal schwannoma: a case series and review of the literature. (2003) (147)
- EphB4 expression and biological significance in prostate cancer. (2005) (142)
- Endoscopic management of upper urinary tract transitional cell carcinoma (2003) (138)
- Androgen deprivation therapy: evidence‐based management of side effects (2013) (138)
- Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial. (2021) (133)
- Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. (2005) (131)
- Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. (2010) (129)
- Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. (2019) (125)
- Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. (2011) (124)
- Active surveillance is the preferred approach to clinical stage I testicular cancer. (2013) (123)
- Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. (2010) (119)
- Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. (2019) (117)
- The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review. (2017) (108)
- Contemporary management of postchemotherapy testis cancer. (2012) (97)
- Factors influencing post‐recurrence survival in bladder cancer following radical cystectomy (2012) (96)
- Adrenal myelolipoma: diagnosis and management. (2006) (96)
- Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. (2012) (92)
- Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. (2013) (91)
- Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway. (2015) (89)
- Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades (2013) (85)
- Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study (2017) (84)
- Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. (2014) (83)
- The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer (2014) (82)
- Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. (2014) (82)
- 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study (2017) (80)
- A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. (2015) (79)
- Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. (2011) (76)
- A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence (2014) (76)
- Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? (2015) (75)
- Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. (2012) (73)
- Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. (2015) (72)
- Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life. (2016) (71)
- Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy (2013) (70)
- Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA (2014) (70)
- Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. (2012) (69)
- The Utility and Reliability of Computed Tomography Scan in the Diagnosis of Small Bowel Obstruction (1999) (68)
- Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. (2018) (68)
- Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. (2013) (68)
- Microscopic and gross extravesical extension in pathological staging of bladder cancer. (2004) (66)
- Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. (2014) (66)
- Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum. (2019) (60)
- Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3‐4aN0M0 Bladder Cancer Treated with Radical Cystectomy (2018) (60)
- Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. (2013) (60)
- The role of pelvic lymphadenectomy for prostate cancer--therapeutic? (2008) (60)
- Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016 (2019) (60)
- Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) (2014) (60)
- Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. (2015) (57)
- Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. (2020) (53)
- Molecular Characterization of Neuroendocrine-like Bladder Cancer (2019) (53)
- A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer (2012) (52)
- Natural history of surgically treated bladder carcinoma with extravesical tumor extension (2003) (52)
- Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. (2013) (50)
- Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer (2014) (50)
- Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer (2017) (49)
- Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. (2014) (48)
- Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma (2015) (47)
- New molecular markers for bladder cancer detection (2004) (46)
- Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018 (2019) (46)
- Adjuvant Surgery in Testicular Cancer Patients Undergoing Postchemotherapy Retroperitoneal Lymph Node Dissection (2012) (46)
- Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. (2018) (46)
- Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. (2013) (46)
- Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes (2014) (45)
- Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments. (2019) (45)
- Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm. (2017) (45)
- Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics (2012) (44)
- Orthotopic urinary diversion (2015) (44)
- Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol. (2017) (44)
- IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC). (2020) (42)
- Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer (2011) (42)
- Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer. (2016) (41)
- Molecular prognostication in bladder cancer--a current perspective. (2003) (41)
- Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. (2014) (40)
- Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node‐positive bladder cancer who are unfit for or who decline adjuvant chemotherapy (2014) (40)
- Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. (2012) (39)
- Resection of the inferior vena cava without reconstruction for urologic malignancies. (2009) (39)
- Endoscopic management of renal hemangioma. (2002) (38)
- SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer (2019) (37)
- Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control. (2014) (37)
- Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. (2003) (37)
- Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. (2016) (36)
- Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results (2020) (35)
- Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer. (2015) (35)
- Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures. (2016) (35)
- Urinary functional outcomes in female neobladder patients (2014) (34)
- Distinctive Morphology of Renal Cell Carcinomas in Tuberous Sclerosis (2010) (34)
- Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. (2016) (34)
- Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. (2014) (33)
- Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. (2016) (33)
- Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy (2010) (32)
- Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. (2015) (32)
- Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. (2014) (32)
- Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. (2012) (32)
- Review of techniques to remove a Foley catheter when the balloon does not deflate. (2002) (32)
- Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy. (2012) (31)
- Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. (2014) (31)
- A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) (2021) (31)
- Utility and significance of ureteric frozen section analysis during radical cystectomy (2016) (31)
- Genitourinary tumors, non-prostate (2012) (31)
- Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients (2018) (31)
- Growing teratoma syndrome: Clinical and radiographic characteristics (2014) (31)
- Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy (2013) (30)
- Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling (2012) (30)
- Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. (2020) (30)
- Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. (2015) (29)
- Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease (2017) (29)
- Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer. (2005) (29)
- Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review (2014) (28)
- Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience (2012) (28)
- Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival (2016) (28)
- The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. (2019) (27)
- Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. (2016) (27)
- Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma. (2015) (27)
- Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. (2016) (27)
- Primary Renal Carcinoid Tumor (2004) (26)
- Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. (2013) (26)
- Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. (2004) (26)
- Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer. (2020) (25)
- Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. (2020) (25)
- Angiomyolipoma of the Kidney: Expanding Disease Spectrum Demonstrated by 3 Cases (2004) (25)
- SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer. (2019) (25)
- Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity. (2017) (25)
- Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol (2016) (24)
- Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis (2021) (23)
- Venous resection in urological surgery. (2008) (23)
- Development and acceptability testing of a patient decision aid for urinary diversion with radical cystectomy. (2019) (22)
- Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder. (2014) (22)
- Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy. (2019) (22)
- Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies (2017) (21)
- Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatment. (2017) (21)
- The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer (2004) (20)
- 1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy (2020) (20)
- Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. (2019) (20)
- Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. (2019) (19)
- Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. (2016) (19)
- Management of residual mass in nonseminomatous germ cell tumors following chemotherapy (2011) (19)
- Reprogramming of the human intestinal epigenome by surgical tissue transposition (2014) (19)
- Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. (2018) (19)
- Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient’s undergoing urologic oncology surgery: a systematic review (2020) (19)
- Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy (2015) (19)
- Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective study. (2020) (19)
- Continent right colon reservoir using a cutaneous appendicostomy. (2004) (18)
- Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle- invasive bladder cancer (MIBC): HCRN GU 16-257. (2021) (18)
- Principal component analysis based pre‐cystectomy model to predict pathological stage in patients with clinical organ‐confined bladder cancer (2013) (18)
- Role of surgical resection for refractory germ cell tumors. (2015) (18)
- Intraoperative renal cell carcinoma tumor embolization to the right atrium: incidental diagnosis by transesophageal echocardiography. (2006) (18)
- SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma. (2021) (18)
- Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy. (2020) (18)
- Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? (2012) (18)
- Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011). (2016) (18)
- Radical cystectomy with super‐extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes (2016) (18)
- Enhanced recovery pathway following radical cystectomy (2014) (17)
- Colourachal fistula in an adult presenting with feculent umbilical drainage. (2003) (17)
- Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. (2019) (17)
- Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes (2015) (17)
- The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol (2018) (17)
- Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors. (2015) (17)
- Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma (2018) (17)
- Determining the role of cystectomy for high-grade T1 urothelial carcinoma. (2013) (16)
- The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. (2018) (16)
- Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer. (2019) (16)
- Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy (2015) (16)
- Enhanced Endoscopy in Bladder Cancer (2018) (16)
- Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. (2020) (16)
- Application of the Yang-Monti channel in adult continent cutaneous urinary diversion. (2007) (16)
- Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor. (2012) (16)
- Satisfaction With Testicular Prosthesis After Radical Orchiectomy. (2017) (16)
- Long‐term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy (2013) (15)
- Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis (2018) (15)
- Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? (2019) (15)
- Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States. (2019) (15)
- Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy (2014) (15)
- Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients (2016) (14)
- Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. (2016) (14)
- Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). (2018) (14)
- Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor. (2019) (14)
- Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi‐Institutional Study (2017) (14)
- Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi‐institutional Retrospective Study (2017) (14)
- Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor. (2014) (14)
- Patient‐reported outcomes of blue‐light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study (2018) (14)
- Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. (2020) (13)
- Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors. (2013) (13)
- Association of higher institutional volume with improved overall survival in clinical stage III testicular cancer: Results from the National Cancer Data Base (1998-2011). (2014) (13)
- Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases (2021) (13)
- Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma. (2020) (13)
- Baseline Glomerular Filtration Rate and Cisplatin‐ Induced Renal Toxicity in Urothelial Cancer Patients (2017) (13)
- Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival. (2020) (13)
- Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue. (2005) (12)
- Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes (2013) (12)
- Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era. (2016) (12)
- Prospective evaluation of blue‐light flexible cystoscopy with hexaminolevulinate in non‐muscle‐invasive bladder cancer (2020) (12)
- The Prognostic Significance of S–Phase Analysis in Stage Ta/T1 Bladder Cancer (2000) (12)
- The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. (2011) (12)
- Oncological Outcomes After Radical Prostatectomy for High‐Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases (2017) (12)
- Orthotopic urinary diversion in the elderly (2015) (11)
- Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer. (2019) (11)
- Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. (2014) (11)
- Diagnosis and Staging of Bladder Cancer. (2021) (11)
- United States trends in patterns of care in clinical stage I testicular cancer: Results from the National Cancer Database (1998-2011). (2014) (10)
- Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members. (2020) (10)
- A phase II trial of neoadjuvant dasatinib (Neo-D) in muscle-invasive urothelial carcinoma of the bladder (miUCB): Hoosier Oncology Group GU07-122 trial. (2012) (10)
- Androgen-producing testicular germ cell tumors. (2011) (10)
- Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men (2018) (10)
- Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy (2018) (10)
- Testicular Mesothelioma: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors. (2019) (10)
- Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy (2018) (10)
- Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy (2012) (10)
- A randomized phase II study of erdafitinib (ERDA) versus intravesical chemotherapy (IC) in patients with high-risk nonmuscle invasive bladder cancer (HR-NMIBC) with FGFR mutations or fusions, who recurred after Bacillus Calmette-Guérin (BCG) therapy. (2020) (10)
- Effect of GemRIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC). (2017) (10)
- The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol (2018) (9)
- Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy. (2017) (9)
- Renal angiomyolipoma with liposarcomatous transformation: a case report and review of the literature. (2004) (9)
- Bilateral Segmental Testicular Infarction (2007) (9)
- Evaluation of the UroVysion™ Test to Predict Recurrence and/or Progression of Disease After BCG for Primary High Grade Non-Muscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. (2019) (9)
- Frailty and preoperative risk assessment before radical cystectomy (2019) (9)
- Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines. (2020) (9)
- Phase II study of gemcitabine, oxaliplatin, and paclitaxel (GOT) on a 2-weekly schedule in patients (pts) with refractory germ cell tumor (rGCT): Final results. (2013) (9)
- Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer. (2019) (9)
- Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer. (2016) (8)
- Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples (2021) (8)
- Current clinical trials in renal cell carcinoma. (2005) (8)
- Dose dense MVAC prior to radical cystectomy: a real-world experience (2017) (8)
- PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations. (2020) (8)
- Sarcomatoid renal cell carcinoma with massive osteosarcomatous differentiation: an unusual image in clinical urology. (2003) (8)
- MP65-02 A PHASE III SURGICAL TRIAL TO EVALUATE THE BENEFIT OF A STANDARD VERSUS AN EXTENDED PELVIC LYMPHADENECTOMY PERFORMED AT TIME OF RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER: SWOG S1011 (NCT #01224665) (2015) (8)
- Is Frozen Section Analysis of Ureteral Margins at Time of Radical Cystectomy Useful? (2015) (8)
- Circulating miR-371a-3p for the detection of low volume viable germ cell tumor: Expanded pilot data, clinical implications and future study. (2018) (8)
- Restrictive transfusion in radical cystectomy is safe. (2017) (8)
- Occult nodal metastases in patients down-staged to non-muscle invasive disease following neoadjuvant chemotherapy. (2020) (8)
- Biologic activity of dasatinib administered as neoadjuvant therapy preceding radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). (2014) (8)
- Sonography of Spermatic Cord Leiomyoma (2004) (8)
- Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results. (2019) (8)
- Re: Appendiceal substitution following right proximal ureter injury. (2009) (7)
- Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma (2016) (7)
- Evaluation and Preservation of Fertility in Patients with Testicular Cancer. (2011) (7)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis (2020) (7)
- Lymph node dissection in bladder cancer: Where do we stand? (2017) (7)
- Modern Management of Testicular Cancer. (2018) (7)
- Internal audit of an enhanced recovery after surgery protocol for radical cystectomy (2020) (7)
- Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer (2021) (7)
- Use of Nonabsorbable Staples for Urinary Diversion: A Step in the Wrong Direction (2012) (7)
- Molecular Prognostication in Bladder Cancer. (2018) (7)
- Minimally invasive postchemotherapy retroperitoneal lymph node dissection: caution and prudence. (2013) (6)
- Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor. (2011) (6)
- Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. (2014) (6)
- Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer. (2022) (6)
- Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study (2018) (6)
- Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy (2016) (6)
- Neuroendocrine differentiation in prostate cancer (2005) (6)
- Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors. (2020) (6)
- Perioperative Outcome of Suprarenal Resection of Vena Cava without Reconstruction in Urologic Malignancies: A Case Series and Review of the Literature. (2020) (6)
- Continent Cutaneous Diversion. (2018) (6)
- 288: Comparison of Extraperitoneal and Intra-Peritoneal Augmentation Enterocystoplasty for Neurogenic Bladder in Spinal Cord Injury Patients (2005) (5)
- Current controversies on the role of lymphadenectomy for bladder cancer. (2019) (5)
- Mesenteric lymphadenopathy in testicular germ cell tumor. (2014) (5)
- Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. (2018) (5)
- Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma (2020) (5)
- Enhanced Recovery After Surgery Pathways: Role and Outcomes in the Management of Muscle Invasive Bladder Cancer. (2018) (5)
- 514 ENHANCED RECOVERY AFTER SURGERY IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER (2013) (5)
- National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. (2020) (5)
- Proceedings of the American Society for Enhanced Recovery/Evidence Based Peri-Operative Medicine 2016 Annual Congress of Enhanced Recovery and Perioperative Medicine (2016) (5)
- Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response. (2020) (5)
- A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer (2021) (5)
- The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma (2021) (5)
- Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective? (2021) (4)
- Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (2021) (4)
- Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy (2019) (4)
- Association of molecular subtypes with pathologic response in a phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy (NAC) for localized, muscle-invasive bladder cancer (SWOG S1314; NCT02177695). (2020) (4)
- Evolving treatment paradigms for locally advanced and metastatic prostate cancer (2006) (4)
- Long‐term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder (2022) (4)
- Surgical strategies for postchemotherapy testis cancer. (2020) (4)
- MP13-03 IMPACT OF SYNCHRONOUS BLADDER CANCER ON RECURRENCE-FREE SURVIVAL AFTER SURGICAL TREATMENT FOR PRIMARY URETHRAL CANCER: RESULTS FROM THE INTERNATIONAL COLLABORATION ON PRIMARY URETHRAL CARCINOMA (ICPUC) (2014) (4)
- Management of chemotherapy-induced remissions in patients with disseminated nonseminomatous germ cell tumors: A review of 98 consecutive patients (2008) (4)
- Impact of Non-guideline-directed Care on Quality of Life in Testicular Cancer Survivors. (2020) (4)
- Multiparametric cystoscopy: is the future here yet? (2020) (4)
- The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial. (2022) (4)
- Active surveillance for low-risk prostate cancer – in pursuit of a standardized protocol (2020) (4)
- Access to high-volume surgeons and the opportunity cost of performing radical prostatectomy by low-volume providers. (2017) (4)
- Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer. (2021) (4)
- Safety and feasibility of urological procedures in Jehovah’s Witness patients (2021) (4)
- Role of blue‐light cystoscopy in detecting invasive bladder tumours: data from a multi‐institutional registry (2021) (4)
- BLUE LIGHT FLEXIBLE CYSTOSCOPY (BLFC) WITH HEXAMINOLEVULINATE (HAL) AND WHITE LIGHT FLEXIBLE CYSTOSCOPY: A PROSPECTIVE, COMPARATIVE, WITHIN‐PATIENT CONTROLLED MULTI‐CENTER PHASE 3 STUDY IN THE DETECTION OF BLADDER CANCER DURING SURVEILLANCE: PPTLBA‐02 (2017) (4)
- PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring FGFR3 alterations. (2020) (4)
- 1907 LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2013) (4)
- Clinical stage II seminoma: management options (2021) (3)
- Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings. (2020) (3)
- Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma (2021) (3)
- Management of extraretroperitoneal masses in germ cell tumor. (2019) (3)
- Intricacies of retroperitoneal lymph node dissection for testis cancer (2021) (3)
- High-grade T1 Urothelial Carcinoma: Where Do We Stand? (2019) (3)
- Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol (2021) (3)
- Optimizing Outcomes in Urological Surgery: Postoperative Care (2020) (3)
- Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit (2021) (3)
- Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study. (2021) (3)
- 1134 RENAL FUNCTION FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC ILEAL NEOBLADDER (2011) (3)
- Development and validation of an objective scoring tool to evaluate surgical dissection: Dissection Assessment for Robotic Technique (DART). (2021) (3)
- Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy (2018) (3)
- Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome. (2016) (3)
- Micro RNA-371a-3p as a blood-based biomarker in testis cancer (2021) (3)
- Growing Teratoma Syndrome of Testicular Origin. (2019) (3)
- Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons (2021) (3)
- Continent Urinary Diversion in the Elderly (2015) (3)
- 1911 FACTORS INFLUENCING LYMPH NODE YIELD DURING RADICAL CYSTECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY: SINGLE-INSTITUTION EXPERIENCE WITH A STANDARDIZED DISSECTION TEMPLATE (2012) (3)
- Short-term Change in Renal Function in Patients Undergoing Continent vs Noncontinent Urinary Diversions (2013) (3)
- Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. (2022) (3)
- Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy (2019) (3)
- Outcomes of surveillance in unselected patients with clinical stage I testicular germ cell tumors: Results of a modern single institution series (2007) (3)
- Reporting radical cystectomy outcomes following implementation of Enhanced Recovery after Surgery (ERAS) protocols: A systematic review and individual patient data meta-analysis (2020) (3)
- An emerging role for immuno-nutrition in patients undergoing radical cystectomy (2021) (3)
- Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: A long-term, single-center study. (2019) (3)
- Bladder Cancer: Advances and Innovations. (2020) (3)
- MP27-10 POST-OPERATIVE PAIN MANAGEMENT AFTER RADICAL CYSTECTOMY: COMPARING TRADITIONAL AND ENHANCED RECOVERY AFTER SURGERY PROTOCOL AT USC (2015) (3)
- Association between epithelial tumor markers’ trends during the course of treatment and oncological outcomes in urothelial bladder cancer (2017) (3)
- Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway. (2019) (3)
- Management of difficult germ-cell tumors. (2006) (3)
- Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. (2022) (2)
- Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank (2016) (2)
- Development and Validation of Contouring Guidelines for Postcystectomy Adjuvant Radiation of Bladder Cancer (2015) (2)
- Zero, Some Chemotherapy Game in Early-Stage Germ Cell Tumors. (2020) (2)
- MP24-04 USE OF RPLND IN TESTICULAR CANCER IN THE UNITED STATES: RESULTS FROM THE NATIONAL CANCER DATA BASE (1998-2011) (2015) (2)
- 1769 INTRAVESICAL LOCATION OF THE TUMOR: HOW DOES IT AFFECT THE PATTERN OF LYMPH NODE METASTASIS AND ONCOLOGICAL OUTCOME IN UROTHELIAL CANCER OF BLADDER? (2013) (2)
- 943 PROGNOSTIC FACTORS AND OUTCOMES AFTER DEFINITIVE TREATMENT FOR PRIMARY URETHRAL CANCER: RESULTS FROM THE INTERNATIONAL COLLABORATION ON PRIMARY URETHRAL CARCINOMA (2013) (2)
- PREDICTIVE ROLE OF 18F-FLOURODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (PET) IN ADVANCED SEMINOMA FOLLOWING CHEMOTHERAPY (2008) (2)
- CONTINENCE IN ELDERLY PATIENTS FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC ILEAL NEOBLADDER (2009) (2)
- Colocalycostomy for repair of ureterojejunal fistula. (2012) (2)
- PD35-06 VENA CAVOSCOPY IN THE ASSESSMENT OF INTRALUMINAL VENA CAVAL TUMOR INVOLVEMENT (2015) (2)
- Radical cystectomy: Techniques and outcomes (2015) (2)
- Adenomatous Polyp of the Verumontanum Causing Bladder Outlet Obstruction (2004) (2)
- MP55-11 DEVELOPMENT AND EXTERNAL VALIDATION OF NOMOGRAMS PREDICTING DISEASE-FREE AND CANCER SPECIFIC SURVIVAL AFTER RADICAL CYSTETCOMY (2014) (2)
- Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk. (2022) (2)
- MP10-12 URINARY TRACT INFECTION FOLLOWING RADICAL CYSTECTOMY WITH AN ENHANCED RECOVERY PROTOCOL (2018) (2)
- MP57-11 DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS (2014) (2)
- MP56-06 COMPLICATIONS OF CONTINENT CUTANEOUS DIVERSIONS (2016) (2)
- Enhanced endoscopy with IMAGE1 S CHROMA improves detection of non-muscle invasive bladder cancer during transurethral resection. (2020) (2)
- Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion. (2021) (2)
- Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer. (2015) (2)
- SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up. (2022) (2)
- Characteristics of relapse in patients with clinical stage I testis cancer undergoing primary surveillance (2008) (2)
- Back to the Future—Moving Forward for Testicular Cancer Survivors (2019) (2)
- Urinary diversion 2015: controversies and new technologies: Choosing the 'right' diversion. (2015) (2)
- Open Partial Nephrectomy for Pediatric Renovascular Hypertension (2009) (2)
- VENOUS THROMBOEMBOLISM RATES FOLLOWING RADICAL CYSTECTOMY STRATIFIED BY METHOD OF PROPHYLAXIS: PD36‐10 (2017) (1)
- 1137 THE IMPACT OF INTESTINAL URINARY DIVERSION ON RENAL FUNCTION (2011) (1)
- Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors. (2023) (1)
- Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center. (2023) (1)
- Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors. (2018) (1)
- Disparities in male versus female oncologic outcomes following bladder preservation: A population‐based cohort study (2021) (1)
- Wearable fitness trackers for measurement of behavioral patterns among patients undergoing radical cystectomy: A pilot study assessing feasibility and utility (2018) (1)
- MP24-06 GENDER BASED VARIATIONS IN THE DETECTION OF BLADDER CANCER WITH BLUE LIGHT CYSTOSCOPY: INSIGHTS FROM A MULTICENTER REGISTRY (2020) (1)
- Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review (2014) (1)
- Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study (2022) (1)
- MP49-03 POPULATION BASED ASSESSMENT OF CONTINENT DIVERSION UTILIZATION AND PERIOPERATIVE MORBIDITY IN THE UNITED STATES (2018) (1)
- Outcomes of radical cystectomy following implementation of enhanced recovery after surgery protocols: A systematic review (2019) (1)
- MIDLINE EXTRAPERITONEAL APPROACH TO RETROPERITONEAL LYMPH NODE DISSECTION IN TESTICULAR CANCER: MINIMIZING SURGICAL MORBIDITY: MP80‐10 (2017) (1)
- 521 Impact of surgical volume on perioperative outcomes after nephrectomy with tumor thrombectomy (2016) (1)
- DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3‐4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE: MP58‐04 (2017) (1)
- PD9-01 CONTINENCE OUTCOMES FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC NEOBLADDER (2015) (1)
- Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer. (2020) (1)
- THE VALUE OF EXTENDED TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT) IN THE TREATMENT OF BLADDER CANCER (2012) (1)
- IMPACT OF NON‐MODIFIABLE PATIENT FACTORS ON PERIOPERATIVE OUTCOME FOLLOWING RADICAL CYSTECTOMY WITH ENHANCED RECOVERY PROTOCOL: PD36‐02 (2017) (1)
- Validation of plasma miR-371a-3p expression in patients with metastatic and early stage germ cell tumor. (2019) (1)
- PD51-11 REPORTING RADICAL CYSTECTOMY OUTCOMES FOLLOWING IMPLEMENTATION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS (2020) (1)
- Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients (2020) (1)
- Influence of social demographics and African-American race on outcomes in testicular cancer: Analysis of 75,902 patients in the National Cancer database. (2014) (1)
- Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review (2021) (1)
- Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patients. (2022) (1)
- Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403. (2007) (1)
- Detecting Invisible Bladder Cancers with Blue Light Cystoscopy. (2020) (1)
- Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. (2023) (1)
- Association between early postradical cystectomy kidney injury and perioperative outcome in enhanced recovery era. (2023) (1)
- Orthotopic Urinary Diversion in Men (2017) (1)
- 516 BLOOD LOSS DURING RADICAL CYSTECTOMY AND CONCOMITANT TRANSFUSIONS: INFLUENCING FACTORS AND IMPACT ON PATIENT OUTCOMES (2013) (1)
- 799TiP PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations (2020) (1)
- Correction to: Enhanced Endoscopy in Bladder Cancer (2019) (1)
- MP30-13 IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS (2014) (1)
- 1983 FACTORS INFLUENCING POST-RECURRENCE SURVIVAL IN BLADDER CANCER PATIENTS FOLLOWING RADICAL CYSTECTOMY (2011) (1)
- Validation of the cobra nomogram for the prediction of cancer specific survival in patients with bladder cancer treated with radical cystectomy (2019) (1)
- Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer (2022) (1)
- Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics (2022) (1)
- Vena Cavoscopy in the Assessment of Intraluminal Vena Caval Tumor Involvement. (2018) (1)
- 753 AGE IS NOT A CONTRAINDICATION FOR AN ORTHOTOPIC ILEAL NEOBLADDER FOLLOWING RADICAL CYSTECTOMY (2010) (1)
- Longer follow-up data of circulating miR371a-3p expression across the spectrum of germ cell tumors (GCT). (2021) (1)
- Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314. (2022) (1)
- Relationship between hyperphosphatemia with infigratinib (BGJ398) and efficacy in FGFR3-altered advanced/metastatic urothelial carcinoma (aUC). (2020) (1)
- Enhanced recovery after cystectomy in patients with preoperative narcotic use. (2021) (1)
- Clinical Utility of Rigid Blue Light Cystoscopy: Results from a Post Procedure User Survey in a Prospective Multicenter Registry (2021) (1)
- Metastatic adenocarcinoma of the prostate with a testicular mass and cutaneous nodules (2003) (1)
- Prerandomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended versus standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer. (2014) (1)
- Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma (2023) (1)
- MP55-08 PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN A MULTICENTRE COHORT OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER. (2014) (1)
- IMvigor010, a phase III study of adjuvant atezolizumab vs observation in patients (pts) with muscle-invasive urothelial carcinoma (UC) (2017) (1)
- PD33-04 STOMA COMPLICATIONS AND QUALITY OF LIFE IN INDIANA POUCH AND APPENDICO-UMBILICOSTOMY URINARY DIVERSIONS (2019) (1)
- PI-07 A TRANSPLANT-BASED SURGICAL APPROACH MAY IMPROVE POSTOPERATIVE COMPLICATIONS IN CASES OF RENAL CELL CARCINOMA AND TUMOR THROMBUS (2015) (1)
- MP5-01 LONG-TERM CLINICAL OUTCOME AND COMPLICATIONS AFTER RADICAL CYSTECTOMY AND ILEAL CONDUIT (2014) (1)
- Impact of Patient, Surgical, and Perioperative Factors on Discharge Disposition after Radical Cystectomy (2022) (1)
- Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]. (2022) (1)
- 1830 IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS (2013) (1)
- MP23-20 BLUE LIGHT CYSTOSCOPY FOR DIAGNOSIS OF UROTHELIAL BLADDER CANCER: RESULTS FROM A PROSPECTIVE MULTICENTER REGISTRY (2016) (1)
- ERAS for Major Urological Procedures: Evidence Synthesis and Recommendations (2020) (1)
- MP25-16 CLINICAL IMPLICATIONS OF THE URINARY DIVERSION MICROBIOME AFTER RADICAL CYSTECTOMY (2022) (1)
- FACTORS INFLUENCING INTRAOPERATIVE CONVERSION FROM PLANNED ORTHOTOPIC TO NON‐ORTHOTOPIC URINARY DIVERSION DURING RADICAL CYSTECTOMY: PD38‐10 (2017) (1)
- Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341–342 of this issue (2021) (1)
- Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions (2018) (1)
- The Role of Photodocumentation in Surveillance Cystoscopy for Bladder Cancer (2011) (1)
- Management of the Continent Cutaneous Stomal Complications (2012) (1)
- Extended hospital stay after radical cystectomy with enhanced recovery protocol. (2019) (1)
- Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? (2021) (1)
- Incidence, characteristics, and implications of thrombo-embolic events in patients with urothelial carcinoma of the bladder undergoing neoadjuvant chemotherapy. (2016) (1)
- Machine learning to delineate surgeon and clinical factors that anticipate positive surgical margins after robot-assisted radical prostatectomy. (2022) (1)
- Feasibility and outcomes of orthotopic ileal neobladder reconstruction following pelvic irradiation. (2020) (1)
- Survey reveals factors in bladder Ca surveillance non-compliance (2018) (1)
- Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions (2020) (1)
- Reproductive organ involvement in female patients undergoing radical cystectomy. (2013) (1)
- Gemcitabine, Oxaliplatin, and Paclitaxel (GOT) on a 2-Weekly Schedule in Patients (PTS) with Refractory Germ Cell Carcinoma: A Phase II Study Conducted at the University of Southern California (2012) (1)
- MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC) (2015) (1)
- Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion. (2012) (1)
- IS COMPLIANCE TO AN ENHANCED RECOVERY PROTOCOL AFTER RADICAL CYSTECTOMY ASSOCIATED WITH IMPROVED POST OPERATIVE OUTCOMES?: PD58‐03 (2017) (1)
- Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature. (2020) (1)
- 1589 INFLUENCE OF SMOKING HISTORY ON BLADDER CANCER PATIENT OUTCOME FOLLOWING RADICAL CYSTECTOMY (2011) (1)
- 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up. (2022) (1)
- Advanced Testis Cancer. (2019) (1)
- BLUE LIGHT CYSTOSCOPY FOR DIAGNOSIS OF UROTHELIAL BLADDER CANCER: RESULTS FROM A PROSPECTIVE MULTICENTER REGISTRY: MP15‐02 (2017) (1)
- Association between use of ERAS protocols and complications after radical cystectomy (2022) (1)
- Testicular cancer management: Population-wide, rapid case ascertainment to drive early expert engagement and reduced practice variation. (2020) (0)
- 735 Nomogram predicting cancer specific mortality (CSM) after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (BC): Results of an international consortium (2015) (0)
- MP63-10 THE DIAGNOSTIC VALUE OF URINARY CYTOLOGY VERSUS DNA METHYLATION URINE BIOMARKER TEST FOR SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER (2023) (0)
- PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL (2022) (0)
- RECURRENT NON‐MUSCLE INVASIVE UROTHELIAL CARCINOMA TUMORS HAVE COMMON ANCESTRAL CLONE: MP65‐10 (2017) (0)
- Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium (2017) (0)
- PD41-09 FACTORS DETERMINING LYMPH NODE YIELD DURING RADICAL CYSTECTOMY WITH PELVIC LYMPHADENECTOMY BEFORE AND AFTER IMPLEMENTING NODE-PACKETING (2015) (0)
- 1868 PROGNOSTIC VALUE OF BAJORIN CRITERIA FOR CANCER-SPECIFIC SURVIVAL IN PATIENTS WHO HAVE DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER (2013) (0)
- MP56-07 ONCOLOGICAL OUTCOMES IN HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPARING GLEASON 8 VERSUS 9,10 DISEASE (2015) (0)
- Implementing Blue Light Flexible Cystoscopy in Non-Muscle Invasive Bladder Cancer Surveillance (2019) (0)
- Partial versus radical nephrectomy in patients with renal cell carcinoma and renal or caval thrombus: Oncological and functional outcomes from an individual matched cohort analysis (2017) (0)
- Renal Brucelloma in a Herniated Kidney (2010) (0)
- Evaluation of length, maximum Gleason score, and extension of disease at positive surgical margins during radical prostatectomy. (2014) (0)
- Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. (2023) (0)
- Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy: A 20-year experience. (2022) (0)
- Node Dissection: Caution and Prudence (2012) (0)
- Correction to: Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies (2019) (0)
- Biological and prognostic implications of biopsy upgrading for high‐grade upper tract urothelial carcinoma at nephroureterectomy (2022) (0)
- PD33-11 PROSPECTIVE EVALUATION OF BOWEL FUNCTION FOLLOWING RADICAL CYSTECTOMY AND URINARY DIVERSION USING TWO VALIDATED QUESTIONNAIRES: WHAT ARE THE EFFECTS ON QUALITY OF LIFE? (2019) (0)
- V8-06 BLUE LIGHT CYSTOSCOPY: THE USC EXPERIENCE (2015) (0)
- PD43-04 A URINE-BASED DNA METHYLATION MARKER TEST TO DETECT UPPER TRACT UROTHELIAL CARCINOMA: A PILOT STUDY (2021) (0)
- Association of preoperative testosterone levels with testicular germ cell tumor histology. (2016) (0)
- Lymphovascular invasion in clinical stage I testicular nonseminoma: Potential marker of more aggressive relapses and implications for active surveillance. (2011) (0)
- 1325 LONG-TERM OUTCOMES OF RADICAL PROSTATECTOMY FOR PT3BN0M0 PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN SCREENING ERA (2012) (0)
- Co-primary endpoint analysis of HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle-invasive bladder cancer (MIBC). (2023) (0)
- Carboplatin induction chemotherapy in clinically lymph node-positive bladder cancer (2023) (0)
- Comparison between oncological outcomes of primary versus salvage radical cystectomy for urothelial carcinoma of the bladder. (2020) (0)
- 528 EXTENT OF PELVIC LYMPH NODE DISSECTION IN STRICTLY UNILATERAL TUMOR: PATHOLOGY-BASED EVIDENCE (2013) (0)
- PD63-03 UTILITY OF BLUE LIGHT FLEXIBLE CYSTOSCOPY FOR BLADDER CANCER SURVEILLANCE AFTER INTRAVESICAL THERAPY (2021) (0)
- MP41-04 THE URINARY MICROBIOME AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION (2020) (0)
- 1255 EVOLVING TRENDS IN URINARY DIVERSION FOLLOWING RADICAL CYSTECTOMY: A SINGLE-INSTITUTION EXPERIENCE OVER 25 YEARS (2013) (0)
- PD18-06 DECREASING LENGTH OF HOSPITAL STAY FOLLOWING RADICAL CYSTECTOMY USING MULTIMODAL ENHANCED RECOVERY PROTOCOL (2014) (0)
- Predicting survival after radical cystectomy: Validation of the SPARC score. (2015) (0)
- MP64-17 PERFORMANCE STATUS AFFECTS OVERALL SURVIVAL AFTER LEVEL III & IV INFERIOR VENA CAVA TUMOR THROMBECTOMY WITHOUT CARDIOPULMONARY BYPASS (2014) (0)
- MP65-15 RADICAL CYSTECTOMY IN FEMALE PATIENTS: DOES THE TYPE OF DIVERSION IMPACT THE PERIOPERATIVE OUTCOMES? (2023) (0)
- 1842 RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER–THE USC EXPERIENCE (2011) (0)
- MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION (2022) (0)
- Outcomes of radical cystectomy for micropapillary urothelial carcinoma at the University of Southern California. (2012) (0)
- MP25-02 RADICAL CYSTECTOMY AND URINARY DIVERSION OUTCOMES IN PATIENTS WITH SINGLE VS. DOUBLE KIDNEY: A 2:1 MATCHED-PAIR ANALYSIS (2022) (0)
- MP72-14 CLINICAL LYMPHADENOPATHY (CN+) IN RADICAL CYSTECTOMY(RC)PATIENTS: A TRANSATLANTIC COLLABORATION (2015) (0)
- Female cystectomy with orthotopic urinary diversion: Is fear of urethral recurrence justified? (2016) (0)
- Differential expression of circulating miR375 and miR371 to detect teratoma and viable germ cell malignancy (2019) (0)
- 792: Biochemical and Clinical Outcomes After Radical Prostatectomy for Clinically Localized Prostate Cancer During The Prostate Specific Antigen ERA (2004) (0)
- Conversion from incontinent conduit to continent cutaneous reservoir after renal transplant. (2013) (0)
- 1751 OUTCOME ANALYSIS OF PATIENTS WITH EXCLUSIVELY CARCINOMA IN SITU (CIS) FOLLOWING RADICAL CYSTECTOMY AND NO PREVIOUS HISTORY OF LAMINA PROPRIA INVASION (2011) (0)
- Abstract 2295: Bladder care epigenetic test allows the sensitive early detection of bladder cancer from urine samples (2020) (0)
- EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: PD04‐10 (2017) (0)
- Outcomes in neuroendocrine bladder cancer treated with radical cystectomy. (2016) (0)
- MP33-03 COMPARATIVE COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR STAGE IIA SEMINOMA: INSIGHTS FROM THE SEMS TRIAL (2023) (0)
- Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis (2023) (0)
- The influence of variant histology on survival outcomes of radical cystectomy for bladder cancer. (2012) (0)
- Reply by Authors. (2023) (0)
- 1411 PREDICTION OF SURVIVAL OUTCOMES AFTER RADICAL CYSTECTOMY USING THREE COMORBIDITY INDICES: A PROPOSAL FOR A STANDARDIZED INSTRUMENT (2012) (0)
- Radical Cystectomy (2021) (0)
- Reply by Authors. (2022) (0)
- 918 ADJUVANT SURGERY IN TESTICULAR CANCER PATIENTS UNDERGOING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (2012) (0)
- PD5-04 UNITED STATES TRENDS IN PATTERNS OF CARE IN CLINICAL STAGE I TESTICULAR CANCER: RESULTS FROM THE NATIONAL CANCER DATA BASE (1998-2011) (2014) (0)
- Phase 2 study of the efficacy and safety of erdafitinib in patients (pts) with intermediate-risk non–muscle-invasive bladder cancer (IR-NMIBC) with FGFR3/2 alterations (alt) in THOR-2: Cohort 3 interim analysis. (2023) (0)
- EDITORIAL COMMENT. (2020) (0)
- MP25-03 ORTHOTOPIC NEOBLADDER IN FEMALE PATIENTS WITH BLADDER CANCER: LONG-TERM FUNCTIONAL OUTCOMES AND THE ROLE OF SURGICAL TECHNIQUE (2022) (0)
- Clinical significance of tumor location for ureteroscopic tumor grading in upper tract urothelial carcinoma (2022) (0)
- PREDICTORS OF URINARY RETENTION AFTER RADICAL CYSTECTOMY AND ORTHOTOPIC NEOBLADDER: PD38‐05 (2017) (0)
- PD51-05 FEASIBILITY OF OMITTING CT PELVIS IN PATIENTS WITH STAGE I GERM CELL TUMOR (GCT) ON ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL STUDY (2022) (0)
- 053 Prospective Evaluation of Patient Reported Sexual Health Outcomes in Men Following Radical Cystectomy (2019) (0)
- MP13-08 IMPACT OF PATIENT, SURGICAL, AND PERIOPERATIVE FACTORS ON DISCHARGE DISPOSITION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER (2021) (0)
- Feasibility of neobladder reconstruction after pelvic irradiation. (2020) (0)
- MP61-11 DEVELOPMENT OF A NOMOGRAM PREDICTING DISEASE-FREE AND CANCER SPECIFIC SURVIVAL AFTER RADICAL CYSTECTOMY FOR SQUAMOUS CELL CARCINOMA (2014) (0)
- 2 Molecular Pathways of Bladder Cancer Development and Progression (2018) (0)
- Blue light cystoscopy for diagnosis of urothelial bladder cancer: Results from a multicenter registry (2018) (0)
- PD43-02 EVALUATION OF URINARY CONTINENCE FOLLOWING NERVE SPARING OPEN RADICAL CYSTOPROSTATECTOMY AND ORTHOTOPIC URINARY DIVERSION (2018) (0)
- PD43-01 PROSPECTIVE EVALUATION OF CONTINENCE FOLLOWING OPEN RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION AND THE EFFECT OF PELVIC FLOOR PHYSICAL THERAPY (2018) (0)
- 563 OUTCOMES IN PATIENTS UNDERGOING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR BULKY RETROPERITONEAL MASSES (2010) (0)
- World Journal of Surgery Acknowledgments for Volume 29/ issue 12 (2005) (0)
- CT abdomen only for active surveillance in patients with stage I germ cell tumor (GCT): A multi-institutional study. (2022) (0)
- MP49-16 A CONTEMPORARY REVIEW OF MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR GERM CELL TUMOR (2019) (0)
- 3512 Identifying Patient-Level Barriers to Non-Muscle Invasive Bladder Cancer Treatment and Surveillance Adherence in Low-Income Latino Patients: A Mixed-Methods Study (2019) (0)
- MP08-14 EVALUATION OF THE UROVYSION™ TEST FOR PREDICTING RECURRENCE AND PROGRESSION IN PATIENTS RECEIVING BCG FOR HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (2018) (0)
- A Massive Penile Tumor. (2021) (0)
- PD9-06 LONG-TERM FUNCTIONAL OUTCOME AND COMPLICATIONS AFTER RADICAL CYSTECTOMY AND ORTHOTOPIC NEOBLADDER DIVERSION (2015) (0)
- An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE). (2022) (0)
- PD31-10 OUTCOMES FOLLOWING POST-CYSTECTOMY RECURRENCE OF BLADDER CANCER BASED ON METASTATIC SITE (2015) (0)
- V10-01 BLUE LIGHT CYSTOSCOPY: INITIAL USC EXPERIENCE (2014) (0)
- MP61-15 IMPACT OF GENDER ON POST-CYSTECTOMY BLADDER CANCER OUTCOMES: DIFFERENCES IN OBSERVATIONS BETWEEN MATCHED AND UNMATCHED CASE-CONTROL APPROACHES (2014) (0)
- MP5-06 90-DAY COMPLICATIONS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY ON ENHANCED RECOVERY PROTOCOL (2015) (0)
- MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY (2015) (0)
- The impact of preoperative ASA and serum albumin on early complication and survival rate of patients undergoing radical cystectomy for bladder cancer. (2012) (0)
- Internal audit of an enhanced recovery after surgery for radical cystectomy (2019) (0)
- 524 Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary results of a multicenter study (2016) (0)
- Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort (2023) (0)
- MP58-15 PREDICTING SURVIVAL AFTER RADICAL CYSTECTOMY: VALIDATION OF THE SPARC SCORE (2015) (0)
- V1888 USC TECHNIQUE FOR ROBOT-ASSISTED INTRACORPOREAL STUDER NEOBLADDER (2012) (0)
- Re: Detection rate of CIS during TURBT following shift from PDD to NBI in a single University Hospital. (2022) (0)
- MP73-11 ROLE OF BLUE LIGHT CYSTOSCOPY IN DETECTING INVASIVE BLADDER TUMOR: DATA FROM MULTI-INSTITUTIONAL REGISTRY (2020) (0)
- Mortality from other malignancies in bladder cancer survivors. (2012) (0)
- Editorial Comment. (2016) (0)
- Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review. (2023) (0)
- 1699 IDENTIFYING NOVEL DNA METHYLATION MARKERS TO MONITOR BLADDER CANCER RECURRENCE IN URINE SEDIMENTS FROM TURBT PATIENTS (2013) (0)
- V2-07 CONTINENT RIGHT COLON RESERVOIR USING CUTANEOUS APPENDICOSTOMY (2014) (0)
- MP65-04 PROPHYLACTIC USE OF BIOLOGIC MESH IN ILEAL CONDUIT (PUBMIC): INITIAL REPORT OF A RANDOMIZED CONTROLLED TRIAL (2023) (0)
- Evolution of management of testicular seminoma: Population-based outcomes with decreased utilization of active therapies. (2010) (0)
- PD47-04 NATIVITY AND BLADDER CANCER OUTCOMES IN MULTI-ETHNIC POPULATIONS: A CALIFORNIA CANCER REGISTRY ANALYSIS (2021) (0)
- Influence of facility (Fac) annual caseload (AC) on survival of patients (pts) with respectable urothelial carcinoma (UC) of the bladder. (2018) (0)
- Tolerance of Orthotopic Ileal Neobladders to Radiation Therapy: A Multi-institutional Retrospective Study (2017) (0)
- Clinical validation of the 7th AJCC-TNM nodal staging system in lymph node-positive patients undergoing radical cystectomy. (2012) (0)
- MP40-18 PROSPECTIVE EVALUATION OF PATIENT REPORTED SEXUAL HEALTH OUTCOMES IN MEN FOLLOWING RADICAL CYSTECTOMY (2019) (0)
- IMPACT OF URINARY DIVERSION ON PATIENTS WITH PRE-EXISTING RENAL INSUFFICIENCY (2009) (0)
- Epigenomic profiling of plasma cell-free DNA (cfDNA) to predict bladder cancer recurrence after radical cystectomy. (2019) (0)
- Incidental prostate cancer in patients with radical cystectomy for bladder cancer. (2013) (0)
- MP10-05 INFLUENCE OF RACE ON OUTCOMES IN TESTICULAR CANCER: ANALYSIS OF 75902 PATIENTS IN THE NATIONAL CANCER DATA BASE (2014) (0)
- MP33-01 RISK OF RESIDUAL TERATOMA AFTER COMPLETE RESPONSE FOLLOWING FIRST-LINE CHEMOTHERAPY IN MEN WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMOR AND IGCCCG INTERMEDIATE/POOR PROGNOSIS: A MULTI-INSTITUTIONAL RETROSPECTIVE COHORT STUDY (2023) (0)
- MP86-17 CLINICALLY SIGNIFICANT INCIDENTAL PROSTATE CANCER DETECTED IN RADICAL CYSTOPROSTATECTOMY SPECIMENS (2015) (0)
- Clinical T1 urothelial bladder cancer: USC experience. (2014) (0)
- The Past and Future of Biomarkers in Testicular Germ Cell Tumors (2020) (0)
- MP08-17 BLUE LIGHT CYSTOSCOPY IMPROVES DETECTION RATES FOR UROTHELIAL BLADDER CANCER COMPARED TO WHITE LIGHT CYSTOSCOPY: UPDATED RESULTS FROM A PROSPECTIVE MULTICENTER REGISTRY (2018) (0)
- Editorial comment. (2010) (0)
- Radical cystectomy and urinary diversion outcomes in patients with single vs. double renal unit: A 2:1 matched-pair analysis. (2022) (0)
- Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data (2019) (0)
- Expression of circulating miR375 and miR371 to differentiate teratoma and viable germ cell tumor in patients with post-chemotherapy residual disease. (2020) (0)
- PD41-03 THREE DIMENSIONAL VOLUMETRICS OF INFERIOR VENA CAVA TUMOR THROMBUS PREDICTS SURGICAL OUTCOMES (2019) (0)
- MP67-13 GASTROINTESTINAL COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY USING ENHANCED RECOVERY PROTOCOL (2015) (0)
- Predictors of pathologic response after radical cystectomy for muscle invasive bladder cancer: A population-based analysis. (2018) (0)
- Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples (2021) (0)
- Frailty as a predictor of complications in older patients undergoing radical cystectomy. (2016) (0)
- PD26-01 EFFECT OF ORAL DDAVP ON NIGHT-TIME INCONTINENCE FOLLOWING OPEN RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION (2018) (0)
- PD34-03 THE INCIDENCE AND TREATMENT OF HYPOGONADISM IN PATIENTS WITH TESTICULAR CANCER (2016) (0)
- Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy (2019) (0)
- Impact of perivesical lymph nodes on survival after radical cystectomy. (2014) (0)
- 603 Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment (2012) (0)
- Adjuvant surgery in patients undergoing post-chemotherapy retroperitoneal lymph node dissection. (2011) (0)
- 1587 DIAGNOSTIC AND SURGICAL DELAYS IN BLADDER CANCER AND ITS IMPACT ON CLINICAL OUTCOME (2012) (0)
- Outcomes of radical cystectomy for micropapillary urothelial carcinoma at the University of Southern California. (2012) (0)
- 979 THE IMPACT OF URETHRAL FROZEN SECTION ATYPIA ON URETHRAL RECURRENCE IN PATIENTS WITH INVASIVE BLADDER CANCER (2011) (0)
- IMvigor010: Updated analysis of Overall Survival (OS) by circulating tumour DNA (ctDNA) status in patients with post-operative Muscle-Invasive Urothelial Carcinoma (MIUC) treated with atezolizumab (2022) (0)
- MP33-18 SURGICAL AND ONCOLOGIC OUTCOMES OF SURGERY IN EARLY METASTATIC SEMINOMA: MULTI-INSTITUTIONAL RETROSPECTIVE STUDY (2023) (0)
- 1887 A PRE-CYSTECTOMY MODELING APPROACH FOR PREDICTING PATHOLOGIC STAGE IN CLINICALLY ORGAN CONFINED BLADDER CANCER (2011) (0)
- Baseline GFR and cisplatin-induced renal toxicity in urothelial cancer patients. (2016) (0)
- Role of CA 125, CA19-9 and CEA in predicting outcome following neoadjuvant chemotherapy in muscle invasive bladder cancer. (2021) (0)
- MP06-05 PRECYSTECTOMY EPITHELIAL TUMOR MARKER RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND ITS EFFECT ON ONCOLOGICAL OUTCOMES IN UROTHELIAL BLADDER CANCER (2016) (0)
- The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract (2015) (0)
- MP10-02 RETROPERITONEAL LYMPH NODE DISSECTION AS FIRST-LINE TREATMENT FOR NODE POSITIVE SEMINOMA (2015) (0)
- THE ASSOCIATION BETWEEN BLOOD TYPE AND RISK OF VENOUS THROMBOEMBOLISM FOLLOWING RADICAL CYSTECTOMY: MP21‐16 (2017) (0)
- MP55-12 UROTHELIAL CARCINOMA IN A BLADDER DIVERTICULUM: OUTCOMES AFTER RADICAL CYSTECTOMY (2014) (0)
- MP47-11 SURGICAL APPROACH AS A DETERMINANT FACTOR OF CLINICAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY: DOES ENHANCED RECOVERY AFTER SURGERY (ERAS) LEVEL THE PLAYING FIELD? (2018) (0)
- PD46-02 BLOOD-BASED LIQUID BIOPSY FOR DIAGNOSIS AND SURVEILLANCE OF PRIMARY UPPER TRACT UROTHELIAL CARCINOMA: ROAD TO EMERGING NOVEL BIOMARKER (2023) (0)
- DEVELOPMENT AND VALIDATION OF CYSTECTOMY ASSESSMENT AND SURGICAL EVALUATION (CASE) SCORING FOR MALE RADICAL CYSTECTOMY: MP34‐10 (2017) (0)
- Neoadjuvant chemotherapy for muscle-invasive bladder cancer at the University of Southern California. (2012) (0)
- MP49-13 IMPACT OF MISMANAGEMENT ON QUALITY OF LIFE IN TESTICULAR CANCER SURVIVORS (2019) (0)
- MUCIN 16 IS A MUTATIONAL HOTSPOT FOR NON‐MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: MP65‐11 (2017) (0)
- Surgery in Motion 3 Robotic Intracorporeal Orthotopic Ileal Neobladder : Replicating (2012) (0)
- Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"? (2017) (0)
- MP50-14 PERIOPERATIVE AND ONCOLOGIC OUTCOME OF UPPER TRACT UROTHELIAL CARCINOMA WITH VARIANT HISTOLOGY FOLLOWING RADICAL NEPHROURETERECTOMY (2019) (0)
- MIDLINE EXTRAPERITONEAL RPLND IN TESTIS CANCER: MINIMIZING SURGICAL MORBIDITY: V6‐01 (2017) (0)
- MP50-09 CONTEMPORARY OUTCOMES OF PRIMARY EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE II GERM CELL TUMORS (2023) (0)
- 105 Factors Associated with Testicular Prostheses Availability and Implantation (2017) (0)
- MP68-12 UTILIZING DNA METHYLATION MARKERS TO PREDICT BLADDER CANCER STAGE (2015) (0)
- V378 CONTEMPORARY MANAGEMENT OF THE INFERIOR VENA CAVA TUMOR THROMBUS (2011) (0)
- Early-stage (stage I) seminoma (2018) (0)
- 920 NERVE-SPARING RETROPERITONEAL LYMPH NODE DISSECTION IN METASTATIC TESTICULAR CANCER (2012) (0)
- PD23-09 EPITHELIAL TUMOR MARKERS (CA 125, CA 19-9 AND CEA) TRENDS IN PATIENTS UNDERGOING TREATMENT FOR INVASIVE BLADDER CANCER (2015) (0)
- Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery (2010) (0)
- MP56-17 THE IMPACT OF BASELINE CHRONIC KIDNEY DISEASE ON LONG-TERM SURVIVALS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
- MP83-13 CLINICAL T1 UROTHELIAL CARCINOMA: OUTCOMES FOLLOWING RADICAL CYSTECTOMY (2018) (0)
- 737 The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy (2015) (0)
- CT abdomen only for active surveillance in patient with stage I germ cell tumor. (2020) (0)
- MP56-11 THE ASSOCIATION BETWEEN EARLY POST-RADICAL CYSTECTOMY ACUTE KIDNEY INJURY AND PERIOPERATIVE OUTCOME IN ENHANCED RECOVERY ERA (2022) (0)
- MP59-18 INCIDENCE AND OUTCOMES OF NODAL METASTASIS IN CLINICALLY NON-MUSCLE INVASIVE BLADDER CANCER (2022) (0)
- Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study (2023) (0)
- MP48-13 BLADDER RECURRENCE FOLLOWING DIAGNOSTIC URETEROSCOPY IN PATIENTS UNDERGOING NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER: IS URETERAL ACCESS SHEATH PROTECTIVE? (2021) (0)
- 2 Part 1 : In-hospital Postoperative Considerations (2019) (0)
- 1768 IMPACT OF MICROPAPILLARY UROTHELIAL CARCINOMA VARIANT HISTOLOGY ON SURVIVAL AFTER RADICAL CYSTECTOMY: A MULTI-INSTITUTIONAL ANALYSIS (2013) (0)
- Editorial comment. (2013) (0)
- MP64-13 IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AFTER NEPHRECTOMY WITH TUMOR THROMBECTOMY (2016) (0)
- 600 Patients with unexpected lymph node (LN) positive bladder cancer: Outcome with radical cystectomy (RC) and extended pelvic lymphadenectomy alone (2012) (0)
- V8-09 BLUE LIGHT CYSTOSCOPY: THE USC EXPERIENCE (2016) (0)
- MP61-15 NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE UROTHELIAL BLADDER CANCER (2020) (0)
- MP23-18 PRELIMINARY RESULTS OF A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT THERAPY IN MUSCLE-INVASIVE BLADDER CANCER (2022) (0)
- Pre-cystectomy serum levels of CA19-9, CA125, and CEA: Correlation with pathologic stage and oncologic outcome in urothelial carcinoma of bladder. (2013) (0)
- PD57-09 WHICH FRAILTY ASSESSMENTS ARE MOST PREDICTIVE OF COMPLICATIONS AFTER RADICAL CYSTECTOMY? (2019) (0)
- Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram. (2022) (0)
- PD42-01 PROPENSITY MATCHED COMPARISON OF RADICAL CYSTECTOMY WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC): A MULTI-INSTITUTIONAL STUDY (2022) (0)
- 1406 RADICAL CYSTECTOMY WITH ORTHOTOPIC NEOBLADDER RECONSTRUCTION FOLLOWING PRIOR RADICAL PROSTATECTOMY (2012) (0)
- 629 Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer (2016) (0)
- MP10-18 PITUITARY-LEYDIG AXIS DYSFUNCTION PRIOR TO ORCHIECTOMY IN TESTICULAR GERM CELL CANCER (2015) (0)
- Seminar article Current clinical trials in renal cell carcinoma (2005) (0)
- 1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY (2013) (0)
- PD41-02 OUTCOMES OF SALVAGE RADICAL CYSTECTOMY FOR RECURRENT UROTHELIAL CARCINOMA OF THE BLADDER FOLLOWING DEFINITIVE RADIOTHERAPY (2018) (0)
- P1 Tying the knot on robotic transition: Results of a prospective study on the learning curve and operative time of robotic pediatric urology procedures Moderated poster session 1: Laparoscopy & robotics/Voiding (2017) (0)
- PD27-09 INCIDENCE AND SIGNIFICANCE OF THROMBO-EMBOLIC EVENTS IN BLADDER UROTHELIAL CARCINOMA PATIENTS UNDERGOING NEO-ADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY: RESULTS FROM MULTI-CENTRE NORTH-AMERICAN AND EUROPEAN CONTEMPORARY DATA (2016) (0)
- 1402 EXTENDED LYMPHADENECTOMY WITH RADICAL CYSTECTOMY: CLINICAL AND PATHOLOGIC IMPACT OF SEPARATE LYMPH NODE PACKETS VERSUS EN BLOC SUBMISSION - AN UPDATE (2014) (0)
- Plasma Micro-RNA 371 Expression in Early-Stage Germ Cell Tumors: Are We Ready to Move Toward Biology-Based Decision Making? (2023) (0)
- The influence of variant histology on survival outcomes of radical cystectomy for bladder cancer. (2012) (0)
- MP65-16 PERIVESICAL LYMPH NODES IMPACT SURVIVAL AFTER RADICAL CYSTECTOMY (2014) (0)
- PROSPECTIVE EVALUATION OF CONTINENCE FOLLOWING OPEN RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION AND THE EFFECT OF PELVIC FLOOR PHYSICAL THERAPY: PD38‐09 (2017) (0)
- PD09-03 INVERSE PROBABILITY TREATMENT WEIGHTING COMPARISON OF RADICAL CYSTECTOMY TO TRIMODALITY THERAPY FOR CT2-CT4 MUSCLE INVASIVE BLADDER CANCER (2023) (0)
- Phase 2 study of the efficacy and safety of erdafitinib in patients (pts) with bacillus Calmette-Guérin (BCG)-unresponsive, high-risk non–muscle-invasive bladder cancer (HR-NMIBC) with FGFR3/2 alterations (alt) in THOR-2: Cohort 2 interim analysis results. (2023) (0)
- A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study (2023) (0)
- MP41-01 EVALUATION OF URINARY CONTINENCE FOLLOWING OPEN RADICAL CYSTECTOMY WITH ORTHOTOPIC NEOBLADDER IN FEMALES USING A VALIDATED QUESTIONNAIRE (2020) (0)
- Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer. (2013) (0)
- Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer. (2018) (0)
- Reply by Authors. (2021) (0)
- Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer (2021) (0)
- Adjuvant surgery in patients with testicular cancer undergoing post-chemotherapy retroperitoneal lymph node dissection. (2012) (0)
- Cell-free DNA (cfDNA) whole genome bisulfite sequencing in patients with muscle-invasive bladder cancer patient treated with cystectomy with curative intent. (2019) (0)
- MP65-12 EVALUATION OF LONG-TERM FUNCTIONAL OUTCOMES OF ORTHOTOPIC NEOBLADDER IN THE ELDERLY USING A VALIDATED QUESTIONNAIRE (2023) (0)
- OPERATIVE EXPERIENCE OF U.S. UROLOGY RESIDENTS WITH OPEN AND LAPAROSCOPIC RENAL SURGERY (2009) (0)
- MP39-09 A COMBINATION OF GENOMIC MARKERS AND CLINICAL VARIABLES PROVIDES SUPERIOR PROGNOSTIC PERFORMANCE IN HIGH-RISK BLADDER CANCER FOLLOWING CYSTECTOMY (2014) (0)
- Role of CA 125, CA19-9 and CEA in predicting outcome following neoadjuvant chemotherapy in muscle invasive bladder cancer (2020) (0)
- 905 Extended lymphadenectomy with radical cystectomy: Clinical and pathologic impact of separate lymph node packets versus en bloc submission – an update (2014) (0)
- MP80-06 THE EFFECT OF CHRONIC NARCOTIC USE ON RECOVERY FOLLOWING RADICAL CYSTECTOMY WITH ENHANCED RECOVERY PROTOCOL (2018) (0)
- DOSE DENSE MVAC PRIOR TO RADICAL CYSTECTOMY: A RETROSPECTIVE MULTI‐INSTITUTIONAL EXPERIENCE: MP58‐03 (2017) (0)
- MP65-11 12-YEAR OUTCOMES OF ABNORMAL URETERAL MARGIN FROZEN SECTION DURING RADICAL CYSTECTOMY IN 2,047 PATIENTS (2014) (0)
- Clinical outcomes of male choriocarcinoma: A case series (2008) (0)
- Pediatric genitourinary tumors: Distribution, demographics, and outcomes (2022) (0)
- MP47-06 IMPACT OF VARIANT HISTOLOGY ON RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR UROTHELIAL BLADDER CANCER (2018) (0)
- Molecular markers for screening, detection and prognosis of bladder cancer (2015) (0)
- MP01-17 ASSOCIATION OF DISTANCE TO TREATMENT FACILITY WITH SURVIVAL AND QUALITY OUTCOMES FOLLOWING RADICAL CYSTECTOMY: A MULTI-INSTITUTIONAL STUDY (2016) (0)
- 822 Prognostic factors and outcomes after definitive treatment for primary urethral cancer: Results from the International Collaboration on Primary Urethral Carcinoma (ICPUC) (2013) (0)
- Radiosensitivity of orthotopic ileal neobladders. (2015) (0)
- Oncological outcomes in high-risk prostate cancer after radical prostatectomy based on Gleason score: USC experience with 3,755 cases. (2015) (0)
- MP12-01 SOCIOECONOMIC FACTORS IMPACT METASTATIC TESTICULAR CANCER INCIDENCE AND OUTCOMES (2023) (0)
- Editorial comment. (2013) (0)
- Inverse probability treatment weighting comparison of radical cystectomy to trimodality therapy for cT2-cT4 muscle invasive bladder cancer (2023) (0)
- PD59-07 PERIOPERATIVE MORTALITY FOR RADICAL CYSTECTOMY IN THE MODERN ERA: EXPERIENCE FROM A TERTIARY REFERRAL CENTER (2021) (0)
- Reply by Authors. (2018) (0)
- 1406 EXTENDED LYMPH NODE DISSECTION IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR CANCER: HOW HIGH? (2011) (0)
- Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification (2022) (0)
- 815 Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder (2013) (0)
- 1893 STAGING MUSCLE INVASIVE BLADDER CANCER WITH DYNAMIC GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING (2007) (0)
- Mesenteric lymphadenopathy in patients with germ cell tumor. (2012) (0)
- 1403 OUTCOME WITH RADICAL SURGERY ALONE IN PATIENTS WITH LYMPH NODE POSITIVE BLADDER CANCER UNFIT FOR OR DECLINING ADJUVANT CHEMOTHERAPY (2012) (0)
- PD51-01 EVOLVING TRENDS IN SURGICAL AND ONCOLOGIC OUTCOMES FOLLOWING RADICAL CYSTECTOMY: LONG-TERM EXPERIENCE AT THE UNIVERSITY OF SOUTHERN CALIFORNIA (2021) (0)
- The Prostate Cancer Dilemma Selecting Patients for Active Surveillance, Focal Ablation and Definitive TherapyNelson N. Stone, E. David Crawford, eds. (2016) (0)
- V07-12 TRANSTHORACIC RESECTION OF RETROCRURAL RECURRENCE IN RENAL CELL CARCINOMA (2018) (0)
- MP78-11 ONCOLOGICAL OUTCOMES WITH NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY FOR MALE PATIENTS WITH CT4A UROTHELIAL BLADDER CANCER (2018) (0)
- Adjuvant chemotherapy for bladder cancer: A detailed characterization of factors precluding utilization. (2016) (0)
- Editorial comment. (2012) (0)
- MP54-10 UTILITY OF A URINE-BASED DNA METHYLATION TEST FOR SURVEILLANCE IN NON-MUSCLE INVASIVE BLADDER CANCER: A PILOT STUDY (2022) (0)
- Words of wisdom. Re: use of androgen deprivation therapy for metastatic prostate cancer in older men. (2008) (0)
- PD2-09 PATIENT SATISFACTION WITH TESTICULAR PROSTHESIS AFTER ORCHIECTOMY FOR TESTICULAR CANCER (2015) (0)
- Oncological outcomes following radical cystectomy for urothelial carcinoma of the bladder with positive lymph nodes. (2020) (0)
- SUPRARENAL VENA CAVA RESECTION WITHOUT RECONSTRUCTION: MP30‐20 (2017) (0)
- Blue Light Cystoscopy with Cysview: The USC Experience (2016) (0)
- Genitourinary Cancers (2018) (0)
- Mesenteric lymphadenopathy in patients with germ cell tumor. (2012) (0)
- PD14-06 IS A RESTAGING TURBT NECESSARY IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER IF THE INITIAL TURBT WAS PERFORMED USING BLUE LIGHT? (2022) (0)
- Blue light cystoscopy for detection of invasive bladder tumor: Results from multi-institutional registry (2020) (0)
- Defining Molecular Features Of Local Recurrence In Muscle-Invasive Bladder Cancer (2020) (0)
- 523 Impact of lymph node dissection at the time of radical nephrectomy and tumour thrombectomy on oncological outcomes of patients with renal cell carcinoma and tumour thrombus (2016) (0)
- 1105 CLINICAL OUTCOME OF PATIENTS WITH CT1/CT2 PROSTATE CANCER TREATED WITH OPEN RADICAL PROSTATECTOMY IN THE PSA ERA- THE USC EXPERIENCE (2011) (0)
- PD44-12 RISK FACTORS OF CHRONIC KIDNEY DISEASE DETERIORATION FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
- MP41-05 CHRONIC KIDNEY DISEASE AND RADICAL CYSTECTOMY FOR BLADDER CANCER: PERIOPERATIVE AND ONCOLOGIC OUTCOMES IN 1,214 PATIENTS (2021) (0)
- Abstract B59: Predictors of early versus late biochemical recurrence after open radical prostatectomy in a patient cohort with T2/T3N0M0 prostate cancer treated within the PSA-era (2012) (0)
- MP02-12 UROLOGIC PROCEDURES IN JEHOVAH’S WITNESS PATIENTS: SAFETY AND FEASIBILITY (2018) (0)
- Quality reporting in postchemotherapy retroperitoneal lymph node dissection (2020) (0)
- 640 OUTCOMES OF PATIENTS WITH LYMPH NODE POSITIVE DISEASE FOLLOWING OPEN RADICAL RETROPUBIC PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (2011) (0)
- Voiding Dysfunction After Neobladder Urinary Diversion (2020) (0)
- MP46-06 TRENDS IN PERIOPERATIVE OUTCOMES FOLLOWING MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION: SINGLE TERTIARY CENTER EXPERIENCE (2022) (0)
- Oncologic outcomes following post-cystectomy recurrence of bladder cancer based on metastatic site and role of salvage immunotherapy. (2023) (0)
- Venothromboembolism and radical cystectomy: Prevalence of risk factors and comparison of anticoagulation use. (2014) (0)
- MP73-09 POST-ORCHIECTOMY HORMONE LEVELS IN TESTICULAR GERM CELL TUMORS (2019) (0)
- AUTHOR REPLY. (2020) (0)
- The impact of preoperative ASA and serum albumin on early complication and survival rate of patients undergoing radical cystectomy for bladder cancer. (2012) (0)
- Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study (2022) (0)
- Review Articles Adrenal Myelolipoma: Diagnosis and Management (2006) (0)
- Retroperitoneal LymphNodeDissectionasPrimaryTreatment for Metastatic Seminoma (2018) (0)
- MP63-12 EMPLOYMENT OF A METAGENOMIC APPROACH TO IDENTIFY PUTATIVE PROGNOSTIC BIOMARKERS THAT PERTURB THE CELLULAR CIRCUITRY IN BLADDER CANCER (2019) (0)
- 1430 PRE-CYSTECTOMY SERUM CARBOHYDRATE ANTIGEN 19-9, CARBOHYDRATE ANTIGEN 125, AND CARCINOEMBRYONIC ANTIGEN: PROGNOSTIC VALUE IN UROTHELIAL CARCINOMA OF BLADDER (2013) (0)
- PD35-05 INCIDENCE, RISK FACTORS, AND NATURAL HISTORY OF PARASTOMAL HERNIA FOLLOWING RADICAL CYSTECTOMY AND ILEAL CONDUIT URINARY DIVERSION (2021) (0)
- Editorial comment. (2013) (0)
- MP79-05 RESECTION OF THE INFERIOR VENA CAVA WITHOUT GRAFTING IN ADVANCED UROLOGIC MALIGNANCY (2015) (0)
- Adjuvant infigratinib as targeted therapy for patients with muscle-invasive urothelial carcinoma harboring susceptible FGFR3 genetic alterations: A randomized, double-blind, placebo-controlled, phase 3 trial (PROOF 302). (2022) (0)
- Distinguishing fibrosis/necrosis from teratoma or viable disease in the retroperitoneum in post-chemotherapy, nonseminomatous testicular germ cell tumor using quantitative CT texture analysis. (2018) (0)
- MP56-20 ETIOLOGY, EVALUATION, AND MANAGEMENT OF HEMATURIA FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION (2023) (0)
- PD41-08 CAN BLADDER CANCER GENE EXPRESSION SIGNATURES BE USED TO PREDICT LYMPH NODE METASTASIS AT THE TIME OF RADICAL CYSTECTOMY? (2015) (0)
- An extraperitoneal midline approach to retroperitoneal lymph node dissection to minimize bowel morbidity. (2016) (0)
- RESTRICTIVE TRANSFUSION IN RADICAL CYSTECTOMY IS SAFE: PD36‐07 (2017) (0)
- MP51-06 EVALUATION OF LENGTH, MAXIMUM GLEASON SCORE, AND EXTENSION OF DISEASE AT POSITIVE SURGICAL MARGINS DURING RADICAL PROSTATECTOMY (2014) (0)
- MP61-10 DNA METHYLATION INHIBITORS MAY REVERSE DRUG-RESISTANCE IN HUMAN BLADDER CANCER CELLS (2016) (0)
- 532 Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1? (2015) (0)
- Decreasing length of hospital stay following radical cystectomy using multimodal enhanced recovery protocol. (2014) (0)
- 718 POST-PROSTATECTOMY SURVIVAL OUTCOMES IN PATIENTS WITH PT3 STAGE DISEASE AND LYMPH NODE INVOLVEMENT (PT3N+M0) WITH SUBSEQUENT OBSERVATION OR ADJUVANT THERAPY (2013) (0)
- Adjuvant surgery in patients with testicular cancer undergoing post-chemotherapy retroperitoneal lymph node dissection. (2012) (0)
- Abstract 2274: Whole-genome bisulfite sequencing of cell-free DNA (cfDNA) in muscle-invasive bladder cancer patients to predict the risk of recurrence (2019) (0)
- Abstract 3296: A urine-based DNA methylation marker test to detect upper tract urothelial carcinoma: a prospective pilot study (2023) (0)
- MP17-16 A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER (2020) (0)
- PD29-05 MAJOR UROLOGIC PROCEDURES IN JEHOVAH'S WITNESS POPULATION: A STUDY OF SAFETY AND FEASIBILITY (2015) (0)
- 898 Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy (2014) (0)
- External validation of the Mayo Clinic Stage, Size, Grade, and Necrosis score in patients with renal cell carcinoma and venous tumor thrombus (2017) (0)
- 1751 OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR RECURRENT BLADDER CANCER FOLLOWING PRIOR PARTIAL CYSTECTOMY (2012) (0)
- MP57-12 CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2014) (0)
- cfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC) (2019) (0)
- MP10-06 FACTORS INFLUENCING ICU ADMISSION AND ASSOCIATED OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH ENHANCED RECOVERY PATHWAY (2019) (0)
- MP5-07 BENIGN URETEROENTERIC STRICTURE IN PATIENTS UNDERGOING RADICAL CYSTECTOMY AND URINARY DIVERSION (2014) (0)
- Radical Abdominal Hysterectomy with Anterior Exenteration: Urological Perspectives (2018) (0)
- Incidence and outcomes of nodal metastasis in clinically nonmuscle-invasive bladder cancer. (2022) (0)
- 1132 ORTHOTOPIC URINARY DIVERSION IN MALE PATIENTS WITH PT4A BLADDER CANCER (2011) (0)
- Retroperitoneal Lymph Node Dissection as an Alternative Treatment Strategy for Low Volume, Clinical Stage II Testicular Seminoma: A Survey of Patients and Providers (2019) (0)
- 1905 INTRAPERICARDIAL CONTROL DURING INFERIOR VENA CAVAL THROMBECTOMY WITHOUT CARDIOPULMONARY BYPASS (2013) (0)
- PD33-06 IS PATHOLOGIC DOWNSTAGING AT RADICAL CYSTECTOMY FOR CLINICALLY ORGAN CONFINED BLADDER CANCER ASSOCIATED WITH A BETTER OUTCOME? (2016) (0)
- Feasibility of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation (2020) (0)
- 1400 CLINICAL NODAL STAGING SCORES FOR BLADDER CANCER A NEW PREOPERATIVELY NODAL ASSESSMENT TOOL (2012) (0)
- Role of Extraretroperito neal Surgery in Patients with Metastatic Germ Cell Tumors (2015) (0)
- MP61-20 PELVIC RECURRENCE FOLLOWING RADICAL CYSTECTOMY AND ITS IMPACT ON BLADDER CANCER OUTCOMES (2014) (0)
- Neoadjuvant chemotherapy for muscle-invasive bladder cancer at the University of Southern California. (2012) (0)
- Editorial comment. (2012) (0)
- MP15-09 MACHINE LEARNING AND AUTOMATED PERFORMANCE METRICS TO PREDICT POSITIVE SURGICAL MARGINS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY (2021) (0)
- 1979 INCIDENCE OF LYMPH NODE METASTASES ABOVE THE ILIAC BIFURCATION IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH EXTENDED LYMPH NODE DISSECTION (2011) (0)
- Late Complication of Orthotopic T-Pouch Ileal Neobladder Diversion. (2022) (0)
- 1620 OVER DECADES, RADICAL CYSTECTOMY WITH EXTENDED LYMPHADENECTOMY PROVIDES PREDICTABLE OUTCOMES TO PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER - NOTWITHSTANDING BLADDER CANCER REMAINS AS DEADLY AS 30 YEARS AGO (2013) (0)
- Longitudinal evaluation of plasma miR371 to detect minimal residual disease and early relapse of germ cell tumors. (2023) (0)
- 1043 Impact of synchronous metastasis distribution on survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy (2014) (0)
- Adjuvant Treatment of Residual Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer (2020) (0)
- PD41-04 LONG-TERM RENAL FUNCTION OUTCOMES AFTER RADICAL CYSTECTOMY WITH ORTHOTOPIC NEOBLADDER IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2020) (0)
- Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery pathway (2019) (0)
- MP29-01 COST COMPARISON OF OPEN AND ROBOTIC RADICAL CYSTECTOMY FOR BLADDER CANCER: A PROPENSITY SCORE MATCHED ANALYSIS (2019) (0)
- MP26-04 WEARABLE FITNESS TRACKERS FOR MEASUREMENT OF BEHAVIORAL PATTERNS AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY: A PILOT STUDY ASSESSING FEASIBILITY AND UTILITY (2018) (0)
- 650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy (2015) (0)
- 1647: Pathologic Factors Associated with Positive Lymph Nodes in Renal Cell Carcinoma (2004) (0)
- PD58-04 A COMPREHENSIVE LIQUID BIOPSY TO DETECT PRIMARY UPPER TRACT UROTHELIAL CARCINOMA: A PILOT STUDY (2022) (0)
- Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? (2022) (0)
- Editorial (2020) (0)
- Can Bladder Cancer Biomarkers from Patients Undergoing Cystectomy Predict the Need for Adjuvant Radiotherapy? (2019) (0)
- PD41-01 NATIONAL PRACTICE PATTERNS AND OUTCOMES FOR ADJUVANT RADIOTHERAPY AFTER RADICAL CYSTECTOMY FOR UROTHELIAL BLADDER CANCER (2018) (0)
- The effect of post-discharge intravenous fluid administration on short-term outcomes following radical cystectomy with enhanced recovery protocol (2019) (0)
- MP83-07 RADICAL CYSTECTOMY FOR CLINICAL T1 BLADDER CANCER: DOES TIMING MATTER? (2018) (0)
- PREDICTIVE ROLE OF EPITHELIAL TUMOR MARKER LEVEL ELEVATION AT FOLLOW‐UP FOR TUMOR RECURRENCE AND ONCOLOGICAL OUTCOMES IN UROTHELIAL BLADDER CANCER: PD62‐11 (2017) (0)
- Abstract PO-084: Time from bladder cancer diagnosis and financial toxicity (2020) (0)
- The opportunity cost (OC) of performing radical prostatectomy (RP) by low volume (LV) providers (Prov). (2016) (0)
- Preface. (2019) (0)
- Vena Cava Tumor Thrombus Associated with Renal Angiomyolipoma in a Jehovah's Witness Patient. (2021) (0)
- PD60-08 ONCOLOGICAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER WITH POSITIVE LYMPH NODES (2020) (0)
- Bladder Cancer: Upper Tract Transitional Cell Carcinoma II (2019) (0)
- Iconographies supplémentaires de l'article : Growing Teratoma Syndrome of Testicular Origin (2018) (0)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study (2020) (0)
- MP47-05 TIMELY CYSTECTOMY IS CRITICAL FOR VARIANT HISTOLOGY OF UROTHELIAL BLADDER CANCER (2018) (0)
- 1401 IS THE NODAL YIELD ASSOCIATED WITH OUTCOMES IN BLADDER CANCER PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY (2012) (0)
- LBA02-03 FIRST RESULTS FROM SunRISE-1 IN PATIENTS WITH BCG UNRESPONSIVE HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER RECEIVING TAR-200 IN COMBINATION WITH CETRELIMAB, TAR-200, OR CETRELIMAB ALONE (2023) (0)
- 1904 EXTRANODAL EXTENSION IS A POWERFUL PROGNOSTIC FACTOR IN BLADDER CANCER PATIENTS WITH LYMPH NODE METASTASIS (2012) (0)
- Modern Management of Testicular Cancer (2019) (0)
- Blue light cystoscopy delays time to recurrence in non-muscle invasive bladder cancer patients treated in a real-world setting (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Siamak Daneshmand?
Siamak Daneshmand is affiliated with the following schools:
